Ammara Mushtaq

Ammara Mushtaq, MD

Clinical Assistant Professor

Department: MD-INFECTIOUS DISEASES
Business Phone: (352) 294-5481

About Ammara Mushtaq

Dr. Mushtaq specializes in treatment of general infectious diseases and HIV. Dr. Mushtaq has special interest in treatment of difficult-to treat bacterial infections causing pneumonia, bacteremia, meningitis, skin and soft tissue infections, osteomyelitis, endocarditis and septic arthritis, among others. Other clinical interests include healthcare-associated infections, sepsis, and outpatient parenteral antibiotic therapy (OPAT).

Dr. Mushtaq’s research interests are to understand epidemiology, diagnosis and therapeutics of infections caused by multidrug-resistant Gram-negative bacteria, and antimicrobial stewardship. She collaborates with genomic scientists and microbiologists to understand the genetic context of such drug-resistant bacteria. She has international outreach and collaborations with researchers in the UK and Pakistan to address some of the key questions to improve our understanding of how antibiotic resistant Gram-negative bacteria spread and cause infections. Her current efforts are focused on developing an antimicrobial resistance surveillance network in Southeast Asia. Dr. Mushtaq’s work has been published in reputed journals and books, and has been cited.

Clinical Profile

Subspecialties
  • Infectious Disease
Areas of Interest
  • Asymptomatic HIV infection
  • Asymptomatic bacteriuria
  • Bacterial gastroenteritis
  • Blood culture
  • Cellulitis
  • Ear infection – acute
  • Ear infection – chronic
  • Endocarditis
  • Epidural abscess
  • Gram-negative meningitis
  • Infectious endocarditis
  • Osteomyelitis
  • Pseudomembranous colitis
  • Sepsis
  • Septic arthritis
  • Septic shock
  • Sexually Transmitted Diseases (STD)
  • Sputum Gram stain
  • Surgical wound infection – treatment
  • Urinary tract infection – adults

Research Profile

Areas of Interest
  • Antimicrobial stewardship
  • Development of novel antibiotics
  • Dual-carbapenemase producing bacteria
  • Metallo-β-lactamase producing Gram-negative bacteria
  • Pathogenesis of carbapenem-resistant Enterobacterales
  • Pseudomonas aeruginosa and Acinetobacter baumannii
  • Surveillance of antimicrobial resistance in developing countries

Publications

2022
Alexandra King-promoting Indigenous self-determination.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(22)00019-6. [PMID] 35092799.
2022
ASM Microbe 2022.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(22)00457-1. [PMID] 35870458.
2022
Cheryl Cohen-promoting evidence-based health policy.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(22)00078-0. [PMID] 35218755.
2022
Infectious diseases compensation in the USA: the relative value.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(22)00360-7. [PMID] 35716701.
2022
Najwa Khuri-Bulos-leading paediatric care in the Arab world.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(22)00298-5. [PMID] 35643109.
2022
SHEA Spring Conference 2022.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(22)00300-0. [PMID] 35643101.
2022
Updates in pre-exposure prophylaxis for HIV.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(22)00081-0. [PMID] 35218750.
2022
Updates in sepsis management.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(21)00773-8. [PMID] 34953551.
2021
“It’s worth a shot… or is it?” Notes from the grassroots on vaccine hesitancy and bridging gaps.
Infection control and hospital epidemiology. [DOI] 10.1017/ice.2021.356. [PMID] 34338180.
2021
CROI 2021.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(21)00214-0. [PMID] 33894841.
2021
ECCMID 2021.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(21)00487-4. [PMID] 34450069.
2021
IDWeek 2021.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(21)00634-4. [PMID] 34717807.
2021
Loretta Sweet Jemmott-a voice for the voiceless.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(21)00282-6. [PMID] 34051191.
2021
New guidelines for Lyme disease diagnosis.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(21)00009-8. [PMID] 33515521.
2021
Primary care of patients with HIV.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(20)30925-7. [PMID] 33271066.
2021
SHEA Spring 2021.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(21)00276-0. [PMID] 34051185.
2021
Updates on management of STIs.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(21)00572-7. [PMID] 34562397.
2021
World Microbe Forum 2021.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(21)00409-6. [PMID] 34331880.
2020
IDWeek 2020.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(20)30875-6. [PMID] 33248035.
2020
New guidelines for latent tuberculosis.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(20)30181-X. [PMID] 32222207.
2020
New guidelines to treat bacterial infections.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(20)30799-4. [PMID] 33098778.
2020
Peter Byass.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(20)30742-8. [PMID] 33589097.
2019
Pulmonary complications of influenza infection: a targeted narrative review.
Postgraduate medicine. [DOI] 10.1080/00325481.2019.1592400. [PMID] 30845866.
2019
Repeating blood cultures after initial bacteremia: When and how often?
Cleveland Clinic journal of medicine. [DOI] 10.3949/ccjm.86a.18001. [PMID] 30742578.
2018
Comparison of complications in midlines versus central venous catheters: Are midlines safer than central venous lines?
American journal of infection control. [DOI] 10.1016/j.ajic.2018.01.006. [PMID] 29525366.
2018
Impact of a Multidisciplinary Infection Prevention Initiative on Central Line and Urinary Catheter Utilization in a Long-term Acute Care Hospital.
Open forum infectious diseases. [DOI] 10.1093/ofid/ofy156. [PMID] 30090837.
2018
In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli
Antimicrob Agents Chemother.
2018
New clinical recommendations for Clostridium difficile.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(18)30180-4. [PMID] 29582768.
2017
Implementing an antibiotic stewardship program at a long-term acute care hospital in Detroit, Michigan.
American journal of infection control. [DOI] 10.1016/j.ajic.2017.07.028. [PMID] 29031431.
2017
Updates in tuberculosis diagnosis in the USA.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(17)30018-X. [PMID] 28134117.
2016
Clinical significance of coryneform Gram-positive rods from blood identified by MALDI-TOF mass spectrometry and their susceptibility profiles – a retrospective chart review
Diagn Microbiol Infect Dis ..
2016
Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva
Antimicrob Agents Chemother.
2016
FDA approves broad hepatitis C treatment.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(16)30344-9. [PMID] 27676353.
2016
Highlights from ASM Microbe 2016.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(16)30225-0. [PMID] 27477984.
2016
Highlights from the 26th ECCMID.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(16)30094-9. [PMID] 27301925.
2016
Training in infectious diseases-any takers?
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(16)30095-0. [PMID] 27301926.
2016
UN commits to tackling antimicrobial resistance.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(16)30419-4. [PMID] 27788986.
2015
Highlights from the 25th ECCMID.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(15)00010-9. [PMID] 26008841.
2014
Characterization of plasmids in extensively drug-resistant acinetobacter strains isolated in India and Pakistan
Antimicrob Agents Chemother.
2012
Hand hygiene does work.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(12)70235-9. [PMID] 23099078.

Contact Details

Phones:
Business:
(352) 294-5481
Addresses:
Business Mailing:
PO Box 100289
GAINESVILLE FL 32610
Business Street:
1600 SW ARCHER RD
GAINESVILLE FL 32610